Abstract
Nine years ago, while a postdoc at Imperial College London, I identified a Salmonella effector secreted via the SPI-2 T3SS that reduces MHC-II surface levels (Bayer-Santos etal., 2016). This commentary describes how this discovery came to be and discusses its implications in the development of my independent career.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
